More importantly, MIR210HG knockdown inhibited pancreatic cancer cell glycolysis by regulating the expression of glycolysis-associated HK2 and pyruvate kinase muscle isoform M2 (PKM2). The gene discussed is HK2; the disease is pancreatic neoplasm.